| Etiologies and predictors of 30-day readmission in patients undergoing induction chemotherapy for acute myeloid leukemia S Handa, K Gupta, JS Sidhu, G Petrone, S Rajeeve, K Jatwani Blood 134, 4759, 2019 | 3 | 2019 |
| Routine clinical parameters and laboratory testing predict therapy-related myeloid neoplasms after treatment for breast cancer G Petrone, C Gaulin, A Derkach, A Kishtagari, ME Robson, ... Haematologica 108 (1), 161, 2023 | 2 | 2023 |
| Peritransplantation use of ruxolitinib in myelofibrosis U Ibrahim, GEM Petrone, J Mascarenhas, A Keyzner Biology of Blood and Marrow Transplantation 26 (12), 2177-2180, 2020 | 2 | 2020 |
| Myelodysplastic Syndromes: Trends in Mortality, Costs of Hospitalizations, Length of Stay and Rate of Complications S Handa, G Petrone, K Gupta, A Khan, JS Sidhu, S Rajeeve Blood 134, 1725, 2019 | 2 | 2019 |
| Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk D Tran, JS Beeler, J Liu, B Wiley, ICC Chan, Z Xin, MH Kramer, ... Clinical Cancer Research, OF1-OF9, 2024 | 1 | 2024 |
| Palliative care utilization and mortality in patients who received inpatient chemotherapy. J Anderson, S Handa, G Petrone, N Chowdhury, D Kwon, AS Bhardwaj, ... Journal of Clinical Oncology 40 (16_suppl), e24074-e24074, 2022 | 1 | 2022 |
| Acute myeloid leukemia and cirrhosis: trends in utilization of induction chemotherapy, rate of hospitalizations and mortality G Petrone, S Handa, K Gupta, A Khan, S Rajeeve Blood 134, 3864, 2019 | 1 | 2019 |
| Ivosidenib for Patients with Clonal Cytopenia of Undetermined Significance and Mutations in IDH1 G Petrone, EM Stein, KL Bolton Blood 142, 3253, 2023 | | 2023 |
| Novel use of an objective scoring rubric to guide inpatient chemotherapy stewardship. AS Bhardwaj, P Jain, DP Hernandez, S Handa, G Petrone, J Anderson, ... Journal of Clinical Oncology 40 (28_suppl), 20-20, 2022 | | 2022 |
| Evaluation of inpatient chemotherapy among patients with cancer. G Petrone, N Chowdhury, S Handa, J Anderson, D Kwon, AS Bhardwaj, ... Journal of Clinical Oncology 40 (16_suppl), 6566-6566, 2022 | | 2022 |
| Routine Laboratory Values Can Predict Therapy-related Myeloid Neoplasms In Patients With New Cytopenias After Treatment For Breast Cancer MD Giulia Petrone, MD, Charles Gaulin, MBBS, Andriy Derkach, PhD, Sean ... Blood, The Journal of the American Society of Hematology 136 (Supplement_1), 2020 | | 2020 |
| Is inpatient chemotherapy overutilized? NS Berger, G Petrone, CA Landry, H Huang, CB Smith Journal of Clinical Oncology 38 (29_suppl), 215-215, 2020 | | 2020 |
| Comparison of baseline patient characteristics in immunotherapy versus targeted therapy trials for advanced melanoma. S Handa, G Petrone, JR Rutledge, PA Friedlander Journal of Clinical Oncology 38 (15_suppl), e22012-e22012, 2020 | | 2020 |
